Announcements Trials
Browse Landscape

Phase

Phase 2 75Phase NA 61Phase 1 50Phase 1/2 42Phase 3 22Phase 2/3 5Phase EARLY_PHASE1 3Phase 4 3

Status

Completed 22Unknown 18Recruiting 12Withdrawn 6Terminated 5Not yet recruiting 5Active not recruiting 5

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5Gynecologic 1

Conditions

Breast Neoplasms 9Carcinoma, Non-Small-Cell Lung 8Prostatic Neoplasms 7Recurrence 6Neoplasm Metastasis 5Colorectal Neoplasms 5Stomach Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Neoplasms 4Lymphoma 4Leukemia, Myeloid, Acute 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Ovarian Neoplasms 3Oropharyngeal Neoplasms 3Melanoma 3Lymphoma, Large B-Cell, Diffuse 3Lung Neoplasms 3Glioblastoma 3Gallbladder Neoplasms 3Colonic Neoplasms 3Cholangiocarcinoma 3Thyroid Neoplasms 2Nasopharyngeal Carcinoma 2Myelodysplastic Syndromes 2Mouth Neoplasms 2Leukemia 2Laryngeal Neoplasms 2Hypopharyngeal Neoplasms 2Hyperthermia 2

Interventions

Oxaliplatin 2Bevacizumab 2atezolizumab 1Leucovorin 1Ipilimumab 1Duloxetine Hydrochloride 1Capecitabine 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2/3 × Active not recruiting × Colorectal Neoplasms × Clear all
NCT02758951 2026-03-24

CAIRO6

Catharina Ziekenhuis Eindhoven

Phase 2/3 Active not recruiting
358 enrolled
GastrointestinalGynecologic

Hyperthermia, Colonic Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms

NCT04137107 2026-01-26

Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer

Alliance for Clinical Trials in Oncology

Phase 2/3 Active not recruiting
220 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT05945901 2025-11-18

A Phase II/III Study of HR070803 in Combination With Oxaliplatin, 5-fluorouracil, Calcium Folinate and Bevacizumab Versus FOLFOX in Combination With Bevacizumab for First-line Treatment of Advanced Colorectal Cancer

Jiangsu HengRui Medicine Co., Ltd.

Phase 2/3 Active not recruiting
669 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT03326791 2025-07-31

ASAC

Oslo University Hospital

Phase 2/3 Active not recruiting
466 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT05141721 2025-05-16

A Study of a Patient-Specific Neoantigen Vaccine in Combination With Immune Checkpoint Blockade for Patients With Metastatic Colorectal Cancer

Seattle Project Corporation

Phase 2/3 Active not recruiting
700 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡